Patents by Inventor Kenji Miki
Kenji Miki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220298482Abstract: As a technology for enriching atrial myocytes or ventricular myocytes in a cardiomyocyte-containing cell population induced from stem cells, provided is a method for enriching atrial myocytes or ventricular myocytes in a cardiomyocyte-containing cell population induced from stem cells, the method including a step of collecting atrial myocytes or ventricular myocytes from the cell population by using the expression level of CD151 as an index.Type: ApplicationFiled: August 19, 2020Publication date: September 22, 2022Applicant: Orizuru Therapeutics, Inc.Inventors: Yoshinori YOSHIDA, Kenji MIKI, Misato KOAKUTSU
-
Patent number: 11413842Abstract: A non-crosslinked rubber laminate which is a rubber laminate includes a butyl rubber-containing layer stacked with an ethylene propylene diene rubber and/or ethylene propylene rubber-containing layer, wherein such non-crosslinked rubber laminate is characterized in that the ethylene propylene diene rubber and/or ethylene propylene rubber-containing layer is a rubber-containing layer that contains a low-molecular-weight polyolefin, a phenolic resin, and a crosslinking agent, where: the low-molecular-weight polyolefin is contained by 40 to 70 parts by weight, the phenolic resin is contained by 1 to 4 parts by weight, and the crosslinking agent is contained by at least 1 part by weight, relative to the ethylene propylene diene rubber and/or ethylene propylene rubber constituting a total of 100 parts by weight. An air conditioning hose made of the rubber laminate, for example, can accommodate POE-based lubricating oils and retain vibration absorption characteristics.Type: GrantFiled: October 30, 2017Date of Patent: August 16, 2022Assignee: NICHIRIN CO., LTD.Inventors: Kenji Miki, Ryota Kojima, Yasushi Takeo
-
Patent number: 11401264Abstract: The present invention provides a heterocyclic compound having an activity to promote the maturation of a cardiomyocyte. A compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof has an activity to promote the maturation of a cardiomyocyte, and is useful as a cardiomyocyte maturation promoter.Type: GrantFiled: March 28, 2019Date of Patent: August 2, 2022Assignee: Orizuru Therapeutics, Inc.Inventors: Yoshinori Yoshida, Kenji Miki, Akira Kaieda, Shigeru Kondo, Hiroshi Nara, Yoshinori Ikeura
-
Publication number: 20220145329Abstract: The present invention provides means which is excellent in efficiency with which a nucleic acid is introduced to cardiac muscle cells, especially a transfection method. A method for transfection of a nucleic acid into a cardiac muscle cell of the present invention comprises a step of contacting a composition comprising: a compound represented by the formula (I) or a salt thereof; a structured lipid; and a nucleic acid, with a cell population comprising cardiac muscle cells.Type: ApplicationFiled: August 8, 2019Publication date: May 12, 2022Inventors: Yoshinori Yoshida, Kenji Miki, Satoru Matsumoto
-
Publication number: 20210054406Abstract: A production method comprising the step of forming an aggregate of cells under conditions that permit transfection of the cells with a substance in a non-cell-adhesive container is provided as a technique for producing cells having the desired substance introduced therein on a large scale at a commercial level.Type: ApplicationFiled: March 28, 2019Publication date: February 25, 2021Applicants: Kyoto University, Takeda Pharmaceutical Company LimitedInventors: Yoshinori YOSHIDA, Kenji MIKI, Yasuharu KAMACHI
-
Publication number: 20210024512Abstract: The present invention provides a heterocyclic compound having an activity to promote the maturation of a cardiomyocyte. A compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof has an activity to promote the maturation of a cardiomyocyte, and is useful as a cardiomyocyte maturation promoter.Type: ApplicationFiled: March 28, 2019Publication date: January 28, 2021Applicants: Kyoto University, Takeda Pharmaceutical Company LimitedInventors: Yoshinori YOSHIDA, Kenji MIKI, Akira KAIEDA, Shigeru KONDO, Hiroshi NARA, Yoshinori IKEURA
-
Publication number: 20210009956Abstract: The present invention provides a cardiomyocyte maturation promoter. The present invention provides a cardiomyocyte maturation promoter comprising one or more compounds selected from 2-methoxy-5-((Z)-2-(3,4,5-trimethoxyphenyl)vinyl)phenol, (1-ethyl-1H-benzotriazol-5-yl)methyl (2-(2-methoxy-4-methylphenyl)-4-methyl-1,3-thiazol-5-yl)carbamate, (2?beta)-22-oxovincaleukoblastine, 2-(2-(4-chlorophenyl)ethyl)-6-(2-furyl)-3H-imidazo[4,5-b]pyridine, 4,5-anhydro-1,2-dideoxy-4-methyl-2-((N-(morpholin-4-ylacetyl)-L-alanyl-O-methyl-L-tyrosyl)amino)-1-phenyl-L-threo-pent-3-ulose, 3-(3-methoxyphenyl)-N7,N7-dimethylisoquinoline-1,7-diamine, methyl 4-(2-benzylbenzoyl)-2,5-dimethyl-1H-pyrrole-3-carboxylate, 2?-(4-aminophenyl)-1H,1?H-2,5?-bibenzimidazol-5-amine, and salts thereof.Type: ApplicationFiled: March 28, 2019Publication date: January 14, 2021Applicants: Kyoto University, Takeda Pharmaceutical Company LimitedInventors: Yoshinori YOSHIDA, Kenji MIKI, Shigeru KONDO
-
Publication number: 20200056248Abstract: An object of the present invention is to provide a method for increasing the purity of a type of tissue cell such as an endothelial cell, a hepatocyte, or an insulin-producing cell. The present invention solves the problem by providing a method comprising a step of introducing, into a cell population, an mRNA comprising a nucleic acid sequence recognized by an miRNA specifically expressed in endothelial cells, hepatocytes, or insulin-producing cells.Type: ApplicationFiled: October 22, 2019Publication date: February 20, 2020Inventors: Yoshinori Yoshida, Hirohide Saito, Kenji Miki, Kei Endo, Seiya Takahashi
-
Publication number: 20200040171Abstract: A non-crosslinked rubber laminate which is a rubber laminate includes a butyl rubber-containing layer stacked with an ethylene propylene diene rubber and/or ethylene propylene rubber-containing layer, wherein such non-crosslinked rubber laminate is characterized in that the ethylene propylene diene rubber and/or ethylene propylene rubber-containing layer is a rubber-containing layer that contains a low-molecular-weight polyolefin, a phenolic resin, and a crosslinking agent, where: the low-molecular-weight polyolefin is contained by 40 to 70 parts by weight, the phenolic resin is contained by 1 to 4 parts by weight, and the crosslinking agent is contained by at least 1 part by weight, relative to the ethylene propylene diene rubber and/or ethylene propylene rubber constituting a total of 100 parts by weight. An air conditioning hose made of the rubber laminate, for example, can accommodate POE-based lubricating oils and retain vibration absorption characteristics.Type: ApplicationFiled: October 30, 2017Publication date: February 6, 2020Inventors: Kenji MIKI, Ryota KOJIMA, Yasushi TAKEO
-
Patent number: 10538740Abstract: An object of the present invention is to provide a novel method for sorting cardiomyocytes. Another object of the present invention is to provide a method for producing high-purity cardiomyocytes and a kit used therefor. The present invention provides a method for sorting cardiomyocytes, comprising a step of introducing miRNA-responsive mRNA into a cell group, wherein the miRNA-responsive mRNA consists of a sequence comprising the following (i) and (ii): (i) a nucleic acid specifically recognized by miRNA specifically expressed in cardiomyocytes, and (ii) a nucleic acid corresponding to the coding region of a gene, wherein translation of (ii) the nucleic acid corresponding to the coding region of a gene into protein is regulated by the nucleic acid sequence in (i) above, thereby achieving the aforementioned objects.Type: GrantFiled: March 20, 2015Date of Patent: January 21, 2020Assignee: Kyoto UniversityInventors: Yoshinori Yoshida, Hirohide Saito, Kenji Miki, Kei Endo, Seiya Takahashi
-
Patent number: 10501811Abstract: An object of the present invention is to provide a method for increasing the purity of a type of tissue cell such as an endothelial cell, a hepatocyte, or an insulin-producing cell. The present invention solves the problem by providing a method comprising a step of introducing, into a cell population, an mRNA comprising a nucleic acid sequence recognized by an miRNA specifically expressed in endothelial cells, hepatocytes, or insulin-producing cells.Type: GrantFiled: April 22, 2016Date of Patent: December 10, 2019Assignee: KYOTO UNIVERSITYInventors: Yoshinori Yoshida, Hirohide Saito, Kenji Miki, Kei Endo, Seiya Takahashi
-
Publication number: 20180100203Abstract: An object of the present invention is to provide a method for increasing the purity of a type of tissue cell such as an endothelial cell, a hepatocyte, or an insulin-producing cell. The present invention solves the problem by providing a method comprising a step of introducing, into a cell population, an mRNA comprising a nucleic acid sequence recognized by an miRNA specifically expressed in endothelial cells, hepatocytes, or insulin-producing cells.Type: ApplicationFiled: April 22, 2016Publication date: April 12, 2018Inventors: Yoshinori Yoshida, Hirohide Saito, Kenji Miki, Kei Endo, Seiya Takahashi
-
Publication number: 20170369846Abstract: An object of the present invention is to provide a novel method for sorting cardiomyocytes. Another object of the present invention is to provide a method for producing high-purity cardiomyocytes and a kit used therefor. The present invention provides a method for sorting cardiomyocytes, comprising a step of introducing miRNA-responsive mRNA into a cell group, wherein the miRNA-responsive mRNA consists of a sequence comprising the following (i) and (ii): (i) a nucleic acid specifically recognized by miRNA specifically expressed in cardiomyocytes, and (ii) a nucleic acid corresponding to the coding region of a gene, wherein translation of (ii) the nucleic acid corresponding to the coding region of a gene into protein is regulated by the nucleic acid sequence in (i) above, thereby achieving the aforementioned objects.Type: ApplicationFiled: March 20, 2015Publication date: December 28, 2017Inventors: Yoshinori Yoshida, Hirohide Saito, Kenji Miki, Kei Endo, Seiya Takahashi
-
Patent number: 9822342Abstract: The present invention provides a method for efficiently producing cardiomyocytes from pluripotent stem cells, which method comprises the steps of dissociating embryoid bodies obtained during the production process, and allowing reaggregation of the resulting cells to allow formation of embryoid bodies.Type: GrantFiled: May 9, 2014Date of Patent: November 21, 2017Assignee: KYOTO UNIVERSITYInventors: Shinya Yamanaka, Yoshinori Yoshida, Kenji Miki
-
Patent number: 9463381Abstract: A game apparatus includes a CPU, and the CPU executes game processing of a golf game, and displays a guide path of a circle a part of which is erased in a hitting operation. When the player performs a sliding operation in a clockwise direction so as to trace the guide path, and then inverts the sliding operation in a counterclockwise direction, the player character performs a swing motion according thereto. As to each of backswing, downswing and follow-through, precision, a speed, smoothness of the sliding operation are determined, and in accordance with the results, the movement of a ball is controlled.Type: GrantFiled: December 29, 2010Date of Patent: October 11, 2016Assignee: Nintendo Co., Ltd.Inventor: Kenji Miki
-
Publication number: 20160122716Abstract: The present invention provides a method for efficiently producing cardiomyocytes from pluripotent stem cells, which method comprises the steps of dissociating embryoid bodies obtained during the production process, and allowing reaggregation of the resulting cells to allow formation of embryoid bodies.Type: ApplicationFiled: May 9, 2014Publication date: May 5, 2016Applicant: Kyoto UniversityInventors: Shinya Yamanaka, Yoshinori Yoshida, Kenji Miki
-
Patent number: 8672711Abstract: The invention provides a connector including a body having insulating properties, a conductive shield case surrounding the body, and a first terminal group arrayed in a line in the body. The first terminal group includes a first terminal and a second terminal. The second terminal is disposed adjacent to the first terminal and having a higher impedance than the first terminal. The shield case includes an adjacent portion that is adjacent to at least a portion of the second terminal and on an opposite side to the first terminal. At least one of the portion of the second terminal and the adjacent portion of the shield case is extended in width so as to shorten a distance between the portion of the second terminal and the adjacent portion of the shield case in accordance with an impedance difference between the first terminal and the second terminal.Type: GrantFiled: November 17, 2010Date of Patent: March 18, 2014Assignee: Hosiden CorporationInventors: Hayato Kondo, Kenji Miki
-
Publication number: 20120077557Abstract: A game apparatus includes a CPU, and the CPU executes game processing of a golf game, and displays a guide path of a circle a part of which is erased in a hitting operation. When the player performs a sliding operation in a clockwise direction so as to trace the guide path, and then inverts the sliding operation in a counterclockwise direction, the player character performs a swing motion according thereto. As to each of backswing, downswing and follow-through, precision, a speed, smoothness of the sliding operation are determined, and in accordance with the results, the movement of a ball is controlled.Type: ApplicationFiled: December 29, 2010Publication date: March 29, 2012Applicant: NINTENDO CO., LTD.Inventor: Kenji Miki
-
Publication number: 20110159732Abstract: The invention provides a connector including a body having insulating properties, a conductive shield case surrounding the body, and a first terminal group arrayed in a line in the body. The first terminal group includes a first terminal and a second terminal. The second terminal is disposed adjacent to the first terminal and having a higher impedance than the first terminal. The shield case includes an adjacent portion that is adjacent to at least a portion of the second terminal and on an opposite side to the first terminal. At least one of the portion of the second terminal and the adjacent portion of the shield case is extended in width so as to shorten a distance between the portion of the second terminal and the adjacent portion of the shield case in accordance with an impedance difference between the first terminal and the second terminal.Type: ApplicationFiled: November 17, 2010Publication date: June 30, 2011Applicant: HOSIDEN CORPORATIONInventors: Hayato KONDO, Kenji MIKI
-
Patent number: 7824222Abstract: The invention provides a connector in which, in an over-mold process, it is possible to prevent a molten resin from flowing through inevitable gaps (88, 89) of a shell (80) into the inside of the shell, thereby preventing problems such as that movable portions of contacts (20) become immovable, from arising. The connector of the invention has a plug body (10) in which contacts (20) to be connected to a cable (70) are held by an insulative body (40), the body (40) is shielded by a shell (80) formed by a metal plate, and a part of the plug body (10) is over-molded. The body (40) has sealing portions (41, 42) which are fitted into gaps (88, 89) of the shell (80) to close the gaps (88, 89).Type: GrantFiled: June 12, 2008Date of Patent: November 2, 2010Assignee: Hosiden CorporationInventors: Toshiharu Miyoshi, Kenji Miki